Archana Sadhu is an Endocrinology/Metabolic physician affiliated with Texas A&M Health Science Center. OpenAlex indexes 78 publications with 1,888 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St
Suite 1101
Houston, TX 770302717
Telephone
713-441-0006Registry record last updated 30 Aug 2016.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Amgen Inc.Program year20251 payment
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
52.6%RANK Ligand Inhibitor52.6%Denosumab100%Part B, office-administered≥41 patientsMetabolism & gastrointestinal
28.7%GLP-1 receptor agonist8.8%Ozempic73%Mounjaro23%Trulicity5%Part D<11 patientsInsulin Analog5.3%Humalog Kwikpen U-10020%Novolog Flexpen18%Lantus Solostar17%Insulin Lispro Kwikpen U-10010%Tresiba Flextouch U-1009%Humalog6%Tresiba Flextouch U-2005%Fiasp Flextouch5%Levemir Flexpen5%Novolog4%Part D<11 patients+ 7 more classes in this area
Cardiovascular
11.1%Statin6.5%Atorvastatin Calcium60%Rosuvastatin Calcium27%Pravastatin Sodium14%Part D≥79 patientsCholesterol absorption inhibitor1.5%Ezetimibe100%Part D≥30 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Personal viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetes
American Journal of Transplantation
2026 - Transportation noise exposure and incident type 2 diabetes: A retrospective cohort study in a large U.S. healthcare system
Diabetes Obesity and Metabolism
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Septimus, MD
Texas A&M Health Science Center
Thomas Kent, MD
Texas A&M Health Science Center
Feng Bi
Texas A&M Health Science Center
Patricia Sulak, MD
Texas A&M Health Science Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”